Prof. Dr. Peter Krawitz
Institute for Genomic Statistics and Bioinformatics
pkrawitz@uni-bonn.de View member: Prof. Dr. Peter Krawitz
American journal of medical genetics. Part A
Next-generation phenotyping (NGP) can be used to compute the similarity of dysmorphic patients to known syndromic diseases. So far, the technology has been evaluated in variant prioritization and classification, providing evidence for pathogenicity if the phenotype matched with other patients with a confirmed molecular diagnosis. In a Nigerian cohort of individuals with facial dysmorphism, we used the NGP tool GestaltMatcher to screen portraits prior to genetic testing and subjected individuals with high similarity scores to exome sequencing (ES). Here, we report on two individuals with global developmental delay, pulmonary artery stenosis, and genital and limb malformations for whom GestaltMatcher yielded Cornelia de Lange syndrome (CdLS) as the top hit. ES revealed a known pathogenic nonsense variant, NM_133433.4: c.598C>T; p.(Gln200*), as well as a novel frameshift variant c.7948dup; p.(Ile2650Asnfs*11) in NIPBL. Our results suggest that NGP can be used as a screening tool and thresholds could be defined for achieving high diagnostic yields in ES. Training the artificial intelligence (AI) with additional cases of the same ethnicity might further increase the positive predictive value of GestaltMatcher.
© 2024 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.
PMID: 38725242
Institute for Genomic Statistics and Bioinformatics
pkrawitz@uni-bonn.de View member: Prof. Dr. Peter Krawitz